Synlogic announces data presentations at the society for inherited metabolic disorders (simd) 44th annual meeting

Presentations included full data from both the phase 2 synpheny-1 study in phenylketonuria and phase 1 study for synb1353 as a potential treatment for homocystinuria presentations included full data from both the phase 2 synpheny-1 study in phenylketonuria and phase 1 study for synb1353 as a potential treatment for homocystinuria
SYBX Ratings Summary
SYBX Quant Ranking